Skip to main content

Want a detailed portfolio tracker?

Spruce Biosciences (SPRB) P/E (2020 - 2026)

Spruce Biosciences (SPRB) P/E from Oct 9, 2020 to Jun 3, 2026. The TTM Spruce Biosciences (SPRB) P/E is -1.30. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Spruce Biosciences (SPRB)

YearP/EChange
2026-1.30-19.82%
2025-1.62+390.66%
2024-0.33-84.09%
2023-2.07+255.29%
2022-0.58-76.32%
2021-2.46-94.23%
2020-42.61N/A

Comparison Spruce Biosciences (SPRB) P/E with competitors

Spruce Biosciences (SPRB) P/E is -1.30.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.13%
NBYStablecoin Development Corp0.10-107.89%
ENLVEnlivex Therapeutics Ltd0.15-111.60%
FGENFibroGen Inc0.24-118.53%
TRAWTraws Pharma Inc0.47-136.50%
FBIOFortress Biotech Inc0.71-154.50%
CHRSCoherus Biosciences Inc0.98-175.51%
ORMPOramed Pharmaceuticals Inc1.47-213.74%
AGENAgenus Inc2.05-258.13%
VIVSVivoSim Labs Inc2.54-295.75%
INVAInnoviva Inc3.19-346.14%
CRMDCorMedix Inc3.65-381.43%
ABEOAbeona Therapeutics Inc4.20-424.61%
VXRTVaxart Inc4.26-428.98%
CVACCureVac N.V.4.45-443.18%
SRPTSarepta Therapeutics Inc4.62-456.97%
GLPGGalapagos NV4.86-475.08%
RIGLRigel Pharmaceuticals4.92-479.76%
ZVRAZevra Therapeutics Inc4.97-483.97%
ABUSArbutus Biopharma Corp5.69-539.53%
CGENCompugen Ltd7.38-670.01%
AUPHAurinia Pharmaceuticals Inc9.25-814.17%
ACADAcadia Pharmaceuticals Inc9.59-840.16%
OMEROmeros Corporation9.88-862.96%
PLXProtalix BioTherapeutics Inc9.91-864.95%
SPROSpero Therapeutics Inc10.73-928.68%
ADMAAdma Biologics Inc11.33-974.68%
SVASinovac Biotech Ltd11.44-982.82%
TBPHTheravance Biopharma Inc11.78-1009.11%
HRMYHarmony Biosciences Holdings Inc12.18-1040.28%
TGTXTG Therapeutics Inc13.18-1117.40%
INCYIncyte Corp13.38-1133.04%
SABSSAB Biotherapeutics Inc14.06-1185.21%
XOMAXOMA Corp14.95-1253.72%
REGNRegeneron Pharmaceuticals Inc14.98-1256.42%
PBYIPuma Biotechnology Inc15.05-1261.84%
EXELExelixis Inc15.79-1319.31%
NAGENiagen Bioscience Inc16.35-1362.54%
CPRXCatalyst Pharmaceuticals Inc17.34-1438.95%
MDXGMimedx Group Inc17.38-1441.32%
ARGXArgen X SE23.07-1881.05%
HALOHalozyme Therapeutics Inc23.20-1891.00%
XOMAOXOMA Corp25.34-2056.53%
VRTXVertex Pharmaceuticals Inc25.66-2080.54%
XOMAPXOMA Corp25.67-2081.64%
CTMXCytomX Therapeutics Inc25.70-2083.79%
ASNDAscendis Pharma A/S26.35-2134.45%
RPRXRoyalty Pharma plc - Class A27.50-2222.55%
SLNOSoleno Therapeutics Inc29.02-2339.88%
LGNDLigand Pharmaceuticals Inc - Class B30.19-2430.30%
BMRNBiomarin Pharmaceutical Inc37.51-2995.43%
APLSApellis Pharmaceuticals Inc39.02-3112.30%
KRYSKrystal Biotech Inc39.70-3164.52%
GMABGenmab40.20-3203.58%
ONCBeiGene Ltd67.03-5274.25%
TECHBio-Techne Corp68.59-5395.31%
VCELVericel Corp80.63-6324.30%
PHARPharming Group N.V.87.74-6873.24%
ALNYAlnylam Pharmaceuticals Inc124.93-9744.46%
TLXTelix Pharmaceuticals Ltd139.89-10899.09%
CORTCorcept Therapeutics Inc158.39-12327.12%